Novel Drug Therapy Targets the Gut to Reverse Severe Fatty Liver Disease
In a significant breakthrough for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), researchers at Michigan Medicine have identified a promising experimental compound that reverses the condition by targeting an unlikely…